Howard Konowitz, MD
Anesthesiology · Des Plaines, ILNPI 1457379976
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Biodelivery Sciences International, Inc. at 29.0% of the total. Reporting peaked in 2020 at $156 and has fallen 83.8% since, to $25 in 2025.
Across 19 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biodelivery Sciences International, Inc.$103
- Scilex Pharmaceuticals Inc.$87
- Boston Scientific$55
- Dendreon Pharmaceuticals LLC$52
- Olympus America Inc.$35
- Amgen$22
What the payments were for
- Food & beverage$355100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biodelivery Sciences International, Inc. | 5 | $103 |
| Scilex Pharmaceuticals Inc. | 5 | $87 |
| Boston Scientific | 3 | $55 |
| Dendreon Pharmaceuticals LLC | 2 | $52 |
| Olympus America Inc. | 2 | $35 |
| Amgen | 2 | $22 |
How this compares
$355 in reported general payments places this provider in the 75th percentile of 1,980 anesthesiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 14 | $3,440 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 62 | $970 |
| Duloxetine Hcl | 38 | $615 |
| Pregabalin | 27 | $607 |
| Buprenorphine Hcl | 23 | $604 |
| Celecoxib | 13 | $598 |
| Gabapentin | 42 | $578 |
| Oxcarbazepine | 12 | $368 |
| Tramadol Hcl | 61 | $288 |
| Tizanidine Hcl | 47 | $286 |
| Topiramate | 15 | $104 |
| Diazepam | 13 | $46 |
| Methylprednisolone | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Des Plaines
- Thomas PontinenDes Plaines$20K
- Andrei RakicDes Plaines$12K
- Darrel SaldanhaDes Plaines$10K
- Nishant ShahChicago$2.1M
- Tolga SuvarChicago$303K
- Fiaz AhmedArlington Heights$251K
- Dragan GastevskiChicago$240K
- Edward ObrienUrbana$167K
- Glenn MurphyEvanston$129K
- Randall OstroffBerwyn$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.